Menu
Create an Account
Log in
Home
Activities
Courses and Conferences
HIV In-Person and Virtual Courses
Earn CME From On-Demand Webcasts
The 2022 Ryan White HIV/AIDS Program CLINICAL CONFERENCE
Conference on Retroviruses and Opportunistic Infections
About IAS–USA Courses
Webinars
Upcoming Webinars
2022 On-Demand Webinars
Earn CME From On-Demand Webinars
About Webinars
COVID-19 Dialogue Series
Upcoming Dialogues
On-Demand Dialogues
Topics in Antiviral Medicine
Current Issues
Previous Issues
TAM
Policies and Practices
Resources
Guidelines
HIV Drug Resistance Mutations
Podcasts
On-Demand Webcasts
Slides
Research Collaboration
Useful Resources for COVID-19 Information and Guidance
Practice Question of the Week
Fellow/Student Resources
Other Resources
About
Mission
IAS–USA Scientific Leadership Board
IAS–USA Governance
Core Faculty
Staff
CME
Funding Information
Careers
Donate
Website Policies
FAQs
Contact
Robert E. Fullilove, EdD
Robert E. Fullilove, EdD
Columbia University
Columbia University
New York, New York
Home
Activities
Courses and Conferences
HIV In-Person and Virtual Courses
Earn CME From On-Demand Webcasts
The 2022 Ryan White HIV/AIDS Program CLINICAL CONFERENCE
Conference on Retroviruses and Opportunistic Infections
About IAS–USA Courses
Webinars
Upcoming Webinars
2022 On-Demand Webinars
Earn CME From On-Demand Webinars
About Webinars
COVID-19 Dialogue Series
Upcoming Dialogues
On-Demand Dialogues
Topics in Antiviral Medicine
Current Issues
Previous Issues
TAM
Policies and Practices
Resources
Guidelines
HIV Drug Resistance Mutations
Podcasts
On-Demand Webcasts
Slides
Research Collaboration
Useful Resources for COVID-19 Information and Guidance
Practice Question of the Week
Fellow/Student Resources
Other Resources
About
Mission
IAS–USA Scientific Leadership Board
IAS–USA Governance
Core Faculty
Staff
CME
Funding Information
Careers
Donate
Website Policies
FAQs
Contact
Practice Question of the Week
June 20, 2022: Antiretroviral Therapy During Conception and Pregnancy
Which of the following antiretroviral therapy (ART) regimens is now recommended for all pregnancy-related clinical categories for people with HIV (PWH)?
A. Bictegravir/tenofovir alafenamide/emtricitabine
B. Doravirine/tenofovir disoproxil fumarate/lamivudine
C. Dolutegravir/tenofovir alafenamide/emtricitabine
D. Cabotegravir/rilpivirine
E. Dolutegravir/lamivudine
Watch Presentation
View Related Resources
Leave Feedback
Subscribe
CLOSE
